Searched for
CIPLA STOCK DROP
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Nifty in control of FIIs? The unlucky 13 bluechips facing the hardest institutional selloffForeign investors have significantly reduced holdings in many Nifty companies since September 2024. This has impacted top blue-chip stocks,...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- LIC’s $2 billion contrarian bet: 10 stocks the DII giant bought while the market bledLife Insurance Corporation of India invested nearly $2 billion in 10 stocks during the March quarter's market fall. LIC bought shares in co...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Ahead of Market: 10 things that will decide stock market action on ThursdayNifty 50 and BSE Sensex declined, snapping a three-day rally due to IT and FMCG losses. Rising India VIX signaled caution, though broader t...
- Cipla shares slide 5% after drug major's Q3 net profit drops 57% YoYCipla shares dropped 5% after reporting a 57% year-on-year decline in net profit to Rs 676 crore, impacted by a fall in gRevlimid sales. Re...
- Cipla shares slide 5% after temporary halt in key drug manufacturingCipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek partner. Supply ...
- Dr Reddy's clarifies on 'joint bid' with Bain Capital for CiplaDr Reddy's said in a statement that it will not comment on market speculations over private equity (PE) firm Bain Capital approaching the c...
- Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding th...
- Cipla tanks 5% as promoters sell stake in block dealDr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...
- US show a plus for Cipla, Lupin confident of recoveryThe domestic business grew 6 per cent, showing the impact of a high base effect.
- Analysts downgrade Cipla as company hints at headwindsIn its quarterly investor presentation, Cipla listed some emerging challenges for the next two quarters.
- Pharma stocks fall after BofA-ML downgradePharma cos including Sun Pharma, Lupin, Cadila Healthcare and Cipla weakened on Thursday after BofA-ML's downgrade.
- What to expect from Cipla Q1 numbers due on FridayAlthough, Cipla has remained flat so far in the year 2013, analysts feel that the stock has the potential to move higher in the coming quar...
- Cipla hits 52-week high on robust Q1 earnings; domestic sales reboundCipla surged over 6% in opening trade after it reported a 52% increase in net profit. UBS maintains a 'buy’ on the stock with a target pric...
- Cipla should stabilise at slightly lower level: Avinnash Gorakssakar"From a medium term horizon typically if one were to enter the stock, still reasonable upside of roughly about 14%-15% is possible."
- If Cipla continues to go down, it may not be defensive in near future: Deepak MohoniDeepak Mohoni, Director, trendwatchindia.com in a chat with ET Now gives his outlook on Cipla.
- Cipla: Focus on exports critical to swing in future surprisesCipla reported better-than-expected earnings for the quarter ended December 2009 on account of a drop in other expenses and marginally lowe...
- Cipla net down 30% at Rs 120 crDomestic pharma major Cipla posted results below market expectations for the first quarter ended June.
Load More
